The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
113981193 11398119 3 F 2009 20160706 20150820 20160713 EXP CA-AMGEN-CANSP2014106314 AMGEN 46.00 YR A F Y 0.00000 20160713 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
113981193 11398119 1 PS ENBREL ETANERCEPT 1 Unknown UNK U 103795 UNKNOWN FORMULATION
113981193 11398119 2 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Unknown 12.5 MG, QWEEK 0 12.5 MG /wk
113981193 11398119 3 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Unknown 20 MG, QWEEK 0 20 MG /wk
113981193 11398119 4 SS LEFLUNOMIDE. LEFLUNOMIDE 1 Unknown 20 MG, UNK 0 20 MG
113981193 11398119 5 SS SULFASALAZINE. SULFASALAZINE 1 Oral 1 G, BID 0 1 G BID
113981193 11398119 6 SS PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 Unknown 400 MG, UNK 0 400 MG
113981193 11398119 7 SS ACTEMRA TOCILIZUMAB 1 Unknown UNK 0
113981193 11398119 8 SS HUMIRA ADALIMUMAB 1 Unknown UNK 0
113981193 11398119 9 SS SIMPONI GOLIMUMAB 1 Unknown UNK 0
113981193 11398119 10 SS ARAVA LEFLUNOMIDE 1 Unknown UNK 0 TABLET
113981193 11398119 11 SS RITUXIMAB RITUXIMAB 1 Unknown UNK 0
113981193 11398119 12 C XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG, BID 0 5 MG BID
113981193 11398119 13 C RITUXAN RITUXIMAB 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
113981193 11398119 1 Rheumatoid arthritis
113981193 11398119 2 Rheumatoid arthritis
113981193 11398119 4 Product used for unknown indication
113981193 11398119 5 Rheumatoid arthritis
113981193 11398119 6 Product used for unknown indication
113981193 11398119 7 Rheumatoid arthritis
113981193 11398119 8 Rheumatoid arthritis
113981193 11398119 9 Rheumatoid arthritis
113981193 11398119 10 Rheumatoid arthritis
113981193 11398119 11 Rheumatoid arthritis
113981193 11398119 12 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
113981193 11398119 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
113981193 11398119 Abdominal discomfort
113981193 11398119 Activities of daily living impaired
113981193 11398119 Adverse event
113981193 11398119 Arthralgia
113981193 11398119 Back pain
113981193 11398119 Crying
113981193 11398119 Depression
113981193 11398119 Drug effect incomplete
113981193 11398119 Drug ineffective
113981193 11398119 Fatigue
113981193 11398119 Joint stiffness
113981193 11398119 Joint swelling
113981193 11398119 Knee arthroplasty
113981193 11398119 Local swelling
113981193 11398119 Malaise
113981193 11398119 Musculoskeletal stiffness
113981193 11398119 Pain
113981193 11398119 Pain in extremity
113981193 11398119 Peripheral swelling
113981193 11398119 Therapy non-responder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
113981193 11398119 2 199911 2008 0
113981193 11398119 3 2010 0
113981193 11398119 4 200205 2005 0
113981193 11398119 5 1997 199911 0
113981193 11398119 6 1999 2008 0
113981193 11398119 7 20140826 0
113981193 11398119 12 20140902 0